Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis.
Poliovirus protein 3A, only 87 amino acids in length, is a potent inhibitor of protein secretion in mammalian cells, blocking anterograde protein traffic from the endoplasmic reticulum (ER) to the Golgi complex. The function of viral protein 3A in blocking protein secretion is extremely sensitive to mutations near the N terminus of the protein. Deletion of the first 10 amino acids or insertion of a single amino acid between amino acids 15 and 16, a mutation that causes a cold-sensitive defect in poliovirus RNA replication, abrogates the inhibition of protein secretion although wild-type amounts of the mutant proteins are expressed. Immunofluorescence light microscopy and immunoelectron microscopy demonstrate that 3A protein, expressed in the absence of other viral proteins, colocalizes with membranes derived from the ER. The precise topology of 3A with respect to ER membranes is not known, but it is likely to be associated with the cytosolic surface of the ER. Although the glycosylation of 3A in translation extracts has been reported, we show that tunicamycin, under conditions in which glycosylation of cellular proteins is inhibited, has no effect on poliovirus growth. Therefore, glycosylation of 3A plays no functional role in the viral replicative cycle. Electron microscopy reveals that the ER dilates dramatically in the presence of 3A protein. The absence of accumulated vesicles and the swelling of the ER-derived membranes argues that ER-to-Golgi traffic is inhibited at the step of vesicle formation or budding from the ER.
Doedens
J R
JR
Department of Molecular, Cellular and Developmental Biology and Howard Hughes Medical Institute, University of Colorado, Boulder 80309, USA.
Giddings
T H
TH
Kirkegaard
K
K
D000595:Amino Acid Sequence; D000818:Animals; D001692:Biological Transport; D019556:COS Cells; D004721:Endoplasmic Reticulum / Q000378:metabolism*; D006031:Glycosylation; D006056:Golgi Apparatus / Q000378:metabolism*; D007425:Intracellular Membranes / Q000378:metabolism; D008969:Molecular Sequence Data; D017955:Poliovirus / Q000187:drug effects / Q000502:physiology*; D011506:Proteins / Q000378:metabolism; D013329:Structure-Activity Relationship; D014415:Tunicamycin / Q000494:pharmacology; D014758:Viral Core Proteins / Q000235:genetics / Q000502:physiology*; D014779:Virus Replication / Q000187:drug effects; D000515:alpha 1-Antitrypsin / Q000235:genetics / Q000378:metabolism
C109349:3A protein, Poliovirus; D011506:Proteins; D014758:Viral Core Proteins; D000515:alpha 1-Antitrypsin; D014415:Tunicamycin